Mersana Therapeutics
MRSN
$3.46
Share price
2.98%
Change (1 day)
-45.94%
Change (1 year)
Categories
Mersana Therapeutics (MRSN) - Cash on Hand
Cash on Hand as of December 2023 : $0.20 B
According to Mersana Therapeutics's latest financial reports the company has $0.20 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Mersana Therapeutics - Cash on Hand chart (from 2016 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.20 B | -25.52% |
| 2022-12-31 | $0.28 B | 57.75% |
| 2021-12-31 | $0.17 B | -30.24% |
| 2020-12-31 | $0.25 B | 155.63% |
| 2019-12-31 | $99.79 M | 42.29% |
| 2018-12-31 | $70.13 M | -38.88% |
| 2017-12-31 | $0.11 B | 14.39% |
| 2016-12-31 | $0.10 B | 769.58% |
| 2015-12-31 | $11.53 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -0.43% | 🇺🇸 USA |